IRB Seminar - Katja Fink, PhD, Director, Antibody Research, Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland
Institute for Research in Biomedicine
Date: 18 June 2019 / 12:00 - 13:00
Katja Fink, PhD
"The human B cell response to dengue virus infection"
Director, Antibody Research, Humabs BioMed SA, a subsidiary of Vir Biotechnology, Bellinzona, Switzerland.
Tuesday, June 18, 2019 at 12:00
IRB Conference Room
Institute for Research in Biomedicine (IRB)
Via Vincenzo Vela 6
CH-6500 Bellinzona
